These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9177373)

  • 21. The cytochrome P450 aromatase lacking exon 5 is associated with a phenotype of nonclassic aromatase deficiency and is also present in normal human steroidogenic tissues.
    Pepe CM; Saraco NI; Baquedano MS; Guercio G; Vaiani E; Marino R; Pandey AV; Flück CE; Rivarola MA; Belgorosky A
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):698-705. PubMed ID: 17608756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypogonadotropic hypogonadism in severe beta-thalassemia: effect of chelation and pulsatile gonadotropin-releasing hormone therapy.
    Wang C; Tso SC; Todd D
    J Clin Endocrinol Metab; 1989 Mar; 68(3):511-6. PubMed ID: 2493034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of estrogen replacement therapy on bone and glucose metabolism in a male with congenital aromatase deficiency.
    Herrmann BL; Janssen OE; Hahn S; Broecker-Preuss M; Mann K
    Horm Metab Res; 2005 Mar; 37(3):178-83. PubMed ID: 15824973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypothalamic-pituitary-gonadal axis in two men with aromatase deficiency: evidence that circulating estrogens are required at the hypothalamic level for the integrity of gonadotropin negative feedback.
    Rochira V; Zirilli L; Genazzani AD; Balestrieri A; Aranda C; Fabre B; Antunez P; Diazzi C; Carani C; Maffei L
    Eur J Endocrinol; 2006 Oct; 155(4):513-22. PubMed ID: 16990650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human models of aromatase deficiency.
    Zirilli L; Rochira V; Diazzi C; Caffagni G; Carani C
    J Steroid Biochem Mol Biol; 2008 Apr; 109(3-5):212-8. PubMed ID: 18448329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aromatase deficiency: a novel compound heterozygous mutation identified in a Chinese girl with severe phenotype and obvious maternal virilization.
    Zhu WJ; Cheng T; Zhu H; Han B; Fan MX; Gu T; Zhao SX; Liu Y; Cheng KX; Song HD; Qiao J
    Mol Cell Endocrinol; 2016 Sep; 433():66-74. PubMed ID: 27256151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment.
    Maffei L; Murata Y; Rochira V; Tubert G; Aranda C; Vazquez M; Clyne CD; Davis S; Simpson ER; Carani C
    J Clin Endocrinol Metab; 2004 Jan; 89(1):61-70. PubMed ID: 14715828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dominant transmission of prepubertal gynecomastia due to serum estrone excess: hormonal, biochemical, and genetic analysis in a large kindred.
    Binder G; Iliev DI; Dufke A; Wabitsch M; Schweizer R; Ranke MB; Schmidt M
    J Clin Endocrinol Metab; 2005 Jan; 90(1):484-92. PubMed ID: 15483104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel phenotype related to partial loss of function mutations of the follicle stimulating hormone receptor.
    Beau I; Touraine P; Meduri G; Gougeon A; Desroches A; Matuchansky C; Milgrom E; Kuttenn F; Misrahi M
    J Clin Invest; 1998 Oct; 102(7):1352-9. PubMed ID: 9769327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Skeletal effects of long-term estrogen and testosterone replacement treatment in a man with congenital aromatase deficiency: evidences of a priming effect of estrogen for sex steroids action on bone.
    Rochira V; Zirilli L; Madeo B; Aranda C; Caffagni G; Fabre B; Montangero VE; Roldan EJ; Maffei L; Carani C
    Bone; 2007 Jun; 40(6):1662-8. PubMed ID: 17400043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aromatase deficiency, a rare syndrome: case report.
    Baykan EK; Erdoğan M; Özen S; Darcan Ş; Saygılı LF
    J Clin Res Pediatr Endocrinol; 2013; 5(2):129-32. PubMed ID: 23748068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GNRHR mutations in a woman with idiopathic hypogonadotropic hypogonadism highlight the differential sensitivity of luteinizing hormone and follicle-stimulating hormone to gonadotropin-releasing hormone.
    Meysing AU; Kanasaki H; Bedecarrats GY; Acierno JS; Conn PM; Martin KA; Seminara SB; Hall JE; Crowley WF; Kaiser UB
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3189-98. PubMed ID: 15240592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endocrine response determines the clinical outcome of pulsatile gonadotropin-releasing hormone ovulation induction in different ovulatory disorders.
    Filicori M; Flamigni C; Meriggiola MC; Ferrari P; Michelacci L; Campaniello E; Valdiserri A; Cognigni G
    J Clin Endocrinol Metab; 1991 May; 72(5):965-72. PubMed ID: 1902487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aromatase deficiency in a Chinese adult man caused by novel compound heterozygous CYP19A1 mutations: effects of estrogen replacement therapy on the bone, lipid, liver and glucose metabolism.
    Chen Z; Wang O; Nie M; Elison K; Zhou D; Li M; Jiang Y; Xia W; Meng X; Chen S; Xing X
    Mol Cell Endocrinol; 2015 Jan; 399():32-42. PubMed ID: 25301327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aromatase deficiency and estrogen resistance: from molecular genetics to clinic.
    Bulun SE
    Semin Reprod Med; 2000; 18(1):31-9. PubMed ID: 11305285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Exon 5 alternative splicing of the cytochrome P450 aromatase could be a regulatory mechanism for estrogen production in humans].
    Pepe CM; Saraco NI; Baquedano MS; Guercio G; Vaiani E; Berensztein E; Rivarola MA; Belgorosky A
    Medicina (B Aires); 2007; 67(4):369-73. PubMed ID: 17891933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The essential role of the aromatase/p450arom.
    Meinhardt U; Mullis PE
    Semin Reprod Med; 2002 Aug; 20(3):277-84. PubMed ID: 12428207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two novel mutations in the gonadotropin-releasing hormone receptor gene in Brazilian patients with hypogonadotropic hypogonadism and normal olfaction.
    Costa EM; Bedecarrats GY; Mendonca BB; Arnhold IJ; Kaiser UB; Latronico AC
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2680-6. PubMed ID: 11397871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized, controlled trial of estradiol replacement therapy in women with hypergonadotropic amenorrhea.
    Taylor AE; Adams JM; Mulder JE; Martin KA; Sluss PM; Crowley WF
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3615-21. PubMed ID: 8855811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The ovarian phenotype of the aromatase knockout (ArKO) mouse.
    Britt KL; Drummond AE; Dyson M; Wreford NG; Jones ME; Simpson ER; Findlay JK
    J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):181-5. PubMed ID: 11850223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.